Ou Bai

2.6k total citations
88 papers, 1.7k citations indexed

About

Ou Bai is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ou Bai has authored 88 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pathology and Forensic Medicine, 32 papers in Oncology and 26 papers in Molecular Biology. Recurrent topics in Ou Bai's work include Lymphoma Diagnosis and Treatment (38 papers), Viral-associated cancers and disorders (17 papers) and Chronic Lymphocytic Leukemia Research (16 papers). Ou Bai is often cited by papers focused on Lymphoma Diagnosis and Treatment (38 papers), Viral-associated cancers and disorders (17 papers) and Chronic Lymphocytic Leukemia Research (16 papers). Ou Bai collaborates with scholars based in China, United States and Canada. Ou Bai's co-authors include Jim Xiang, Jinying Yuan, Xin‐Min Li, Rudy Bowen, Siguo Hao, David Keegan, Jennifer Chlan‐Fourney, Xinmin Li, Zelan Wei and Mabood Qureshi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ou Bai

74 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ou Bai China 18 905 343 329 310 228 88 1.7k
Wendy Lee United States 25 947 1.0× 220 0.6× 177 0.5× 162 0.5× 485 2.1× 56 2.6k
Min Zheng China 27 1.3k 1.5× 419 1.2× 190 0.6× 626 2.0× 317 1.4× 86 2.3k
Jong Wook Chang South Korea 31 1.4k 1.6× 166 0.5× 330 1.0× 318 1.0× 273 1.2× 78 2.8k
Dan Frenkel Israel 17 740 0.8× 387 1.1× 544 1.7× 185 0.6× 260 1.1× 22 2.4k
Marta Joana Costa Jordão Germany 9 775 0.9× 1.2k 3.5× 151 0.5× 290 0.9× 515 2.3× 9 2.5k
Eike Gallmeier Germany 25 1.2k 1.3× 296 0.9× 416 1.3× 466 1.5× 958 4.2× 61 2.6k
Arezou Sayad Iran 23 963 1.1× 272 0.8× 106 0.3× 828 2.7× 232 1.0× 147 1.9k
Anna Jurewicz Poland 18 638 0.7× 468 1.4× 118 0.4× 172 0.6× 123 0.5× 32 1.5k
Yandong Zhao China 20 550 0.6× 115 0.3× 192 0.6× 114 0.4× 200 0.9× 112 1.7k
Yongming Qiu China 28 1.4k 1.6× 176 0.5× 213 0.6× 824 2.7× 286 1.3× 112 2.5k

Countries citing papers authored by Ou Bai

Since Specialization
Citations

This map shows the geographic impact of Ou Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ou Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ou Bai more than expected).

Fields of papers citing papers by Ou Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ou Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ou Bai. The network helps show where Ou Bai may publish in the future.

Co-authorship network of co-authors of Ou Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Ou Bai. A scholar is included among the top collaborators of Ou Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ou Bai. Ou Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Haotian, Ying Zhang, Z Y Li, & Ou Bai. (2024). Characteristics, efficacy, and prognosis analysis of newly diagnosed marginal zone lymphoma. Frontiers in Immunology. 15. 1466859–1466859.
2.
Zhang, Ying, Wei Guo, Haotian Wang, et al.. (2024). Chidamide: A New Exploration of Maintenance Therapy for DLBCL Patients with HBV Infection. Blood. 144(Supplement 1). 4490–4490. 1 indexed citations
3.
4.
Zhang, Ying, et al.. (2024). Carcinogenic mechanisms of virus-associated lymphoma. Frontiers in Immunology. 15. 1361009–1361009. 5 indexed citations
5.
6.
Li, Zhaoxia, Wei Guo, & Ou Bai. (2023). Mechanism of action and therapeutic targeting of CD30 molecule in lymphomas. Frontiers in Oncology. 13. 1301437–1301437. 7 indexed citations
7.
Shi, Yijun, et al.. (2023). Measurement and analysis of the structural resilience of regional networks under the impact of COVID-19. International Journal of Disaster Risk Reduction. 97. 104025–104025. 10 indexed citations
8.
9.
Guo, Wei, Yinping Wang, Jia Li, et al.. (2021). The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone in Untreated PTCL: A Real-World, Retrospective Study. Advances in Therapy. 39(1). 532–543. 4 indexed citations
10.
Guo, Wei, Yuanyuan Song, Wantong Song, et al.. (2020). Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy. Scientific Reports. 10(1). 7832–7832. 59 indexed citations
11.
Liu, Zhihe, et al.. (2017). Swollen lymph nodes may not be clinical manifestations of chronic myeloid leukemia: case report and revision of literature. Therapeutics and Clinical Risk Management. Volume 13. 1159–1162. 1 indexed citations
12.
Liu, Zhihe, et al.. (2017). PD1 is highly expressed in diffuse large B-cell lymphoma with hepatitis B virus infection. PLoS ONE. 12(6). e0180390–e0180390. 6 indexed citations
13.
Liu, Zhihe, et al.. (2017). MYC Gene Rearrangements Are Closely Associated with Poor Survival of Diffuse Large B Cell Lymphoma with Hepatitis B Virus Infection. BioMed Research International. 2017. 1–7. 10 indexed citations
14.
Liu, Zhihe, et al.. (2015). Clinical Analysis of 152 Cases of Multiple Primary Malignant Tumors in 15,398 Patients with Malignant Tumors. PLoS ONE. 10(5). e0125754–e0125754. 46 indexed citations
15.
Yang, Lei, et al.. (2013). Micronucleus Expression and Acute Leukemia Prognosis. Asian Pacific Journal of Cancer Prevention. 14(9). 5257–5261. 10 indexed citations
16.
Xie, Yufeng, Ou Bai, Haifeng Zhang, Wei Li, & Jim Xiang. (2010). Tumor Necrosis Factor Gene-Engineered J558 Tumor Cell–Released Exosomes Stimulate Tumor Antigen P1A-Specific CD8 + CTL Responses and Antitumor Immunity. Cancer Biotherapy and Radiopharmaceuticals. 25(1). 21–28. 29 indexed citations
17.
18.
19.
Hao, Siguo, Zhenmin Ye, Jicheng Yang, Ou Bai, & Jim Xiang. (2006). Intradermal Vaccination of Dendritic Cell–Derived Exosomes Is Superior to a Subcutaneous One in the Induction of Antitumor Immunity. Cancer Biotherapy and Radiopharmaceuticals. 21(2). 146–154. 23 indexed citations
20.
Bai, Ou, Jennifer Chlan‐Fourney, Rudy Bowen, David Keegan, & Xin‐Min Li. (2002). Expression of brain‐derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. Journal of Neuroscience Research. 71(1). 127–131. 217 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy Lee Breakdown of academic impact, for papers by Min Zheng Breakdown of academic impact, for papers by Jong Wook Chang Breakdown of academic impact, for papers by Dan Frenkel Breakdown of academic impact, for papers by Marta Joana Costa Jordão Breakdown of academic impact, for papers by Eike Gallmeier Breakdown of academic impact, for papers by Arezou Sayad Breakdown of academic impact, for papers by Anna Jurewicz Breakdown of academic impact, for papers by Yandong Zhao Breakdown of academic impact, for papers by Yongming Qiu
Rankless by CCL
2026